Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Down-regulation of the cell surface display of class I MHC proteins is an important mechanism of immune evasion by human and animal viruses. Herpesviruses in particular encode a variety of proteins that function to lower MHC I display by several mechanisms. These include binding and retention of MHC I chains in the endoplasmic reticulum, dislocation of class I chains from the ER, inhibition of the peptide transporter (TAP) involved in antigen presentation, and shunting of newly assembled chains to lysosomes. Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is a human herpesvirus strongly linked to the development of KS and to certain AIDS-associated lymphoproliferative disorders. Here we show that KSHV encodes two distinctive gene products that function to dramatically reduce cell surface MHC I expression. These viral proteins are localized predominantly to the ER. However, unlike previously described MHC I inhibitors, they do not interfere with the synthesis, translocation, or assembly of class I chains, nor do they retain them in the ER. Rather, they act to enhance endocytosis of MHC I from the cell surface; internalized class I chains are delivered to endolysosomal vesicles, where they undergo degradation. These KSHV proteins define a mechanism of class I down-regulation distinct from the mechanisms of other herpesviruses and are likely to contribute importantly to immune evasion during viral infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A knowledge base for predicting protein localization sites in eukaryotic cells
Nakai, K., & Kanehisa, M. (1992) · Genomics · doi:10.1016/s0888-7543(05)80111-9 · Cited by 1,511
Wiertz, E. J. H. J., Jones, T. R., Sun, L., Bogyo, M., Geuze, H. J., & Ploegh, H. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81054-5 · Cited by 1,072
Schwartz, O., Maréchal, V., Gall, S. L., Lemonnier, F., & Heard, J.-M. (1996) · Nature Medicine · doi:10.1038/nm0396-338 · Cited by 1,060
Herpes simplex virus turns off the TAP to evade host immunity
Hill, A., Jugovic, P., York, L., Russ, G., Bennink, J., Yewdell, J., Ploegh, H., & Johnson, D. (1995) · Nature · doi:10.1038/375411a0 · Cited by 803
Herpes simplex virus turns off the TAP to evade host immunity
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90181-7 · Cited by 736
A viral inhibitor of peptide transporters for antigen presentation
Früh, K., Ahn, K., Djaballah, H., Sempé, P., van Endert, P. M., Tampé, R., Peterson, P. A., & Yang, Y. (1995) · Nature · doi:10.1038/375415a0 · Cited by 602
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
Ahn, K., Gruhler, A., Galocha, B., Jones, T. R., Wiertz, E. J. H. J., Ploegh, H. L., Peterson, P. A., Yang, Y., & Früh, K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80349-0 · Cited by 477
Effects of mutant rat dynamin on endocytosis
Herskovits, J., Burgess, C., Obar, R., & Vallee, R. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.3.565 · Cited by 456
Jones, T. R., Wiertz, E. J., Sun, L., Fish, K. N., Nelson, J. A., & Ploegh, H. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11327 · Cited by 414
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
Ahn, K., Angulo, A., Ghazal, P., Peterson, P. A., Yang, Y., & Früh, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.10990 · Cited by 378
Cited by
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Kaposi's sarcoma and its associated herpesvirus
Mesri, E. A., Cesarman, E., & Boshoff, C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2888 · Cited by 880
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Cesarman, E., Damania, B., Krown, S. E., Martin, J., Bower, M., & Whitby, D. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0060-9 · Cited by 697
Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A., & McFadden, G. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141049 · Cited by 666
Viral mechanisms of immune evasion
Alcami, A., & Koszinowski, U. H. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01699-6 · Cited by 548
The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
Zhang, Y., Chen, Y., Li, Y., Huang, F., Luo, B., Yuan, Y., Xia, B., Ma, X., Yang, T., Yu, F., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024202118 · Cited by 535
The MHC class I antigen presentation pathway: strategies for viral immune evasion
Hewitt, E. W. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01738.x · Cited by 487
Natural Killer Cells and Cancer
(2003) · Advances in Cancer Research · doi:10.1016/s0065-230x(03)90004-2 · Cited by 438
MHC class I antigen presentation: learning from viral evasion strategies
Hansen, T. H., & Bouvier, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2575 · Cited by 426
Ubiquitination on Nonlysine Residues by a Viral E3 Ubiquitin Ligase
Cadwell, K., & Coscoy, L. (2005) · Science · doi:10.1126/science.1110340 · Cited by 406
Self-citationViral mechanisms of immune evasion
Alcami, A., & Koszinowski, U. H. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01830-8 · Cited by 362
Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A., & Lukac, D. M. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.2.175-212.2003 · Cited by 352
Brulois, K. F., Chang, H., Lee, A. S.-Y., Ensser, A., Wong, L.-Y., Toth, Z., Lee, S. H., Lee, H.-R., Myoung, J., Ganem, D., et al. (2012) · Journal of Virology · doi:10.1128/jvi.01019-12 · Cited by 348
Self-citationBartee, E., Mansouri, M., Hovey Nerenberg, B. T., Gouveia, K., & Früh, K. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1109-1120.2004 · Cited by 325
HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway
Blagoveshchenskaya, A. D., Thomas, L., Feliciangeli, S. F., Hung, C.-H., & Thomas, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01162-5 · Cited by 305
Arias, C., Weisburd, B., Stern-Ginossar, N., Mercier, A., Madrid, A. S., Bellare, P., Holdorf, M., Weissman, J. S., & Ganem, D. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003847 · Cited by 300
Self-citationMolecular mechanisms of viral oncogenesis in humans
Krump, N. A., & You, J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0064-6 · Cited by 295
Coscoy, L., Sanchez, D. J., & Ganem, D. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200111010 · Cited by 282
Self-citationUbiquitination, Ubiquitin-like Modifiers, and Deubiquitination in Viral Infection
Isaacson, M. K., & Ploegh, H. L. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.012 · Cited by 282
Ubiquitin Ligases and the Immune Response
Liu, Y.-C. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104813 · Cited by 282
Naslavsky, N., Weigert, R., & Donaldson, J. G. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-04-0053 · Cited by 278
Lysine‐63‐linked ubiquitination is required for endolysosomal degradation of class I molecules
Duncan, L. M., Piper, S., Dodd, R. B., Saville, M. K., Sanderson, C. M., Luzio, J. P., & Lehner, P. J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601056 · Cited by 274
Natural killer cells and viral infections
French, A. R., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/s095279150200002x · Cited by 269
Ishido, S., Choi, J.-K., Lee, B.-S., Wang, C., DeMaria, M., Johnson, R. P., Cohen, G. B., & Jung, J. U. (2000) · Immunity · doi:10.1016/s1074-7613(00)00036-4 · Cited by 262
Ensoli, B., Sgadari, C., Barillari, G., Sirianni, M. C., Stürzl, M., & Monini, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00121-6 · Cited by 255
Chapter 1 Antigen Presentation by CD1
Cohen, N. R., Garg, S., & Brenner, M. B. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(09)01201-2 · Cited by 254
The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation
Lin, H., Li, S., & Shu, H.-B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01751 · Cited by 124
Nathan, J. A., Sengupta, S., Wood, S. A., Admon, A., Markson, G., Sanderson, C., & Lehner, P. J. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00747.x · Cited by 87
Huang, T., Lehmann, M. J., Said, A., Ma, G., & Osterrieder, N. (2014) · Journal of Virology · doi:10.1128/jvi.02079-14 · Cited by 24
“It was shown in transiently transfected cells that these two virus-encoded enzymes directly increase endocytic activity and lead to the uptake of MHC-I molecules from the cell surface (19).”
BackgroundMethod
Metadata
- Authors
- Coscoy, L., & Ganem, D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-06-20
- Volume
- 97
- Issue
- 14
- Pages
- 8051-8056
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2069624186
- Cited by
- 476
- References
- 17
- FWCI
- 12.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.